TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

Comparison of 3 preventive TB therapies in patients with HIV infection

Among individuals with HIV infection currently taking antiretroviral therapy (ART), self-administered preventive tuberculosis (TB) therapy with a 3-month course of rifapentine and isoniazid was found to be associated with a significantly increased rate of treatment completion compared with a 6-month course of isoniazid alone, according to results of a study published in Annals of Internal Medicine.

Read the full story at Infectious Disease Advisor.

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By Madison Heck

Published: Sept. 24, 2021, 3:59 p.m.

Last updated: Nov. 14, 2024, 7:52 p.m.

Print Share